Latacz Emily, Verheul Sanne M L, Sillis Yasmine, van Dam Pieter-Jan, Doukas Michail, Grunhagen Dirk J, Nyström Hanna, Dirix Piet, Dirix Luc, Van Laere Steven, Verhoef Cornelis, Vermeulen Peter
Translational Cancer Research Unit, Ziekenhuis aan de Stroom (ZAS), Campus Augustinus, Antwerp, Belgium.
Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.
Clin Exp Metastasis. 2024 Dec 12;42(1):1. doi: 10.1007/s10585-024-10319-w.
The behaviour of metastases in patients with liver-metastatic colorectal cancer (CRC) is still not adequately considered during treatment planning. However, studies in large cohorts have shown that the disease course in these patients depends on the histopathological growth pattern (HGP) of the liver metastases, with the desmoplastic (or encapsulated) pattern responsible for a favourable outcome and the replacement pattern for an unfavourable course. To increase our knowledge of cancer biology in general as well as to design clinical trials that take into account the diverse behaviour of liver metastases, it is necessary to know the cellular and molecular determinants of these growth patterns. For that purpose, we compared the transcriptome of tumour tissue (prospective cohort; n = 57) sampled very precisely at the transition of metastasis and adjacent liver, between the desmoplastic and replacement HGP. In addition, the mutational profiles for 46 genes related to CRC were extracted from the RNA sequencing reads. First, we show that the genetic constitution of a liver metastasis from colorectal cancer does not determine its HGP. Second, we show clear differences between HGPs regarding the expression of genes belonging to the Molecular Signatures Database hallmark gene sets. Biological themes of the replacement HGP reflect cancer cell proliferation and glucose metabolism, while the desmoplastic HGP is characterized by inflammation and immune response, and angiogenesis. This study supports the view that HGPs are a reflection of the biology of CRC liver metastases and suggests the HGPs are driven epigenetically rather than by specific gene mutations.
在制定治疗方案时,仍未充分考虑肝转移性结直肠癌(CRC)患者转移灶的行为。然而,对大型队列的研究表明,这些患者的病程取决于肝转移灶的组织病理学生长模式(HGP),促结缔组织增生性(或包膜性)模式预示着良好的预后,而替代模式则预后不良。为了增进我们对癌症生物学的总体认识,并设计出考虑到肝转移灶不同行为的临床试验,有必要了解这些生长模式的细胞和分子决定因素。为此,我们比较了在转移灶与相邻肝脏交界处非常精确采样的肿瘤组织(前瞻性队列;n = 57)的转录组,比较对象为促结缔组织增生性和替代型HGP。此外,从RNA测序读数中提取了46个与CRC相关基因的突变谱。首先,我们表明结直肠癌肝转移灶的基因构成并不能决定其HGP。其次,我们发现不同HGP在属于分子特征数据库标志性基因集的基因表达方面存在明显差异。替代型HGP的生物学主题反映癌细胞增殖和葡萄糖代谢,而促结缔组织增生性HGP的特征是炎症、免疫反应和血管生成。本研究支持以下观点,即HGP反映了CRC肝转移灶的生物学特性,并表明HGP是由表观遗传驱动而非特定基因突变驱动。